Literature DB >> 18581349

One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients.

Wynnie W M Lam1, W Y Au, Winnie C W Chu, S Tam, S Y Ha, D J Pennell.   

Abstract

PURPOSE: To assess the feasibility of one-stop evaluation of iron load of myocardium, liver, and anterior pituitary gland in thalassemia patients.
MATERIALS AND METHODS: Fifty thalassemia major patients underwent a breath-hold magnetic resonance imaging (MRI) sequence for assessment of T2* for liver and myocardium, a short axis cine trueFISP sequence covering base to apex to assess the ejection fraction of left ventricle, and a turbo spin echo T2-weighted sequence for the anterior pituitary gland. The MRI parameters were correlated with serum growth hormone, insulin growth factor-1 (IGF-1), insulin growth factor binding protein-3 (IGFBP-3), and endocrine failure.
RESULTS: Ferritin was found to be associated with T2* liver (P < 0.005), T2SI (signal intensity) pituitary (P = 0.001), and T2 pituitary/fat (P = 0.001), but not with T2* heart. There was significant correlation of T2SI pituitary with IGF-1 and IGFBP-3. T2* liver (P < 0.001), T2* heart (P < 0.001), pituitary SI (P < 0.001) and pituitary/fat SI (P = 0.002) were also found to be significantly correlated with a history of hypogonadism. T2* heart was also found to be significantly correlated with IGF-1.
CONCLUSION: A quick MRI protocol for assessment of T2* liver, T2* heart, and T2SI pituitary is technically feasible. This might form an objective basis to monitor the response to different organs to chelation therapy. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581349     DOI: 10.1002/jmri.21433

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

1.  Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Li Feng; Wing-Yan Au; Jerry S Cheung; Shau-Yin Ha; Sujit S Sheth; Gary M Brittenham
Journal:  NMR Biomed       Date:  2010-12-28       Impact factor: 4.044

2.  Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload.

Authors:  M Beth McCarville; Claudia M Hillenbrand; Ralf B Loeffler; Matthew P Smeltzer; Ruitan Song; Chin-Shang Li; Jane S Hankins
Journal:  Pediatr Radiol       Date:  2010-03-24

Review 3.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

4.  Pituitary iron and volume imaging in healthy controls.

Authors:  L J Noetzli; A Panigrahy; A Hyderi; A Dongelyan; T D Coates; J C Wood
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-11       Impact factor: 3.825

5.  Myocardial T2 quantitation in patients with iron overload at 3 Tesla.

Authors:  Hua Guo; Wing-Yan Au; Jerry S Cheung; Daniel Kim; Jens H Jensen; Pek-Lan Khong; Queenie Chan; Kevin C Chan; Christina Tosti; Haiying Tang; Truman R Brown; Wynnie W M Lam; Shau-Yin Ha; Gary M Brittenham; Ed X Wu
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

6.  Parametric exploration of the liver by magnetic resonance methods.

Authors:  Paul E Sijens
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

7.  Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Sujit S Sheth; Gary M Brittenham
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

Review 8.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

9.  Treating thalassemia major-related iron overload: the role of deferiprone.

Authors:  Vasilios Berdoukas; Kallistheni Farmaki; Susan Carson; John Wood; Thomas Coates
Journal:  J Blood Med       Date:  2012-10-19

Review 10.  Hypogonadism in thalassemia major patients.

Authors:  Sasima Srisukh; Boonsong Ongphiphadhanakul; Pongamorn Bunnag
Journal:  J Clin Transl Endocrinol       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.